We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Creatine wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
19 of 23 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Armodafinil (Nuvigil) and Creatine have evidence — compare verdict strength side-by-side.
Approved dosing is 150–250 mg once daily in the morning for narcolepsy and OSA, or 150 mg taken ~1 hour before the start of a night shift for shift-work disorder. A prescription drug; off-label cognitive use is not an approved or standardized regimen.
morning
Oral tablet (armodafinil)
5g daily
Any time, Post-workout may have slight advantage
Monohydrate powder
Hours (per dose); weeks for steady benefit
Per dose (acute)
Acute / weeks
Throughout use
2-4 weeks
1-2 weeks
First week
2-4 weeks
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Current medical research and opinion (2006) · Rct · n=196
Pivotal 12-week, multicenter, double-blind, placebo-controlled RCT in 196 narcolepsy patients (armodafinil 150 mg, 250 mg, or placebo once daily)
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Clinical therapeutics (2006) · Rct
12-week, 37-center, double-blind, placebo-controlled RCT of armodafinil 150 or 250 mg as adjunct in nCPAP-adherent OSA/hypopnea patients with residual excessive sleepiness
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
Mayo Clinic proceedings (2009) · Rct · n=254
12-week, 42-site, randomized, double-blind, placebo-controlled RCT in 254 night-shift workers with moderate-or-greater shift work disorder (armodafinil 150 mg vs placebo before each shift)
Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis
Nutrients (2020) · Meta analysis · n=951
Six hundred and fifty-six studies were identified where creatine supplementation was the primary intervention; fifty-eight were female only studies (9%).
International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine
Journal of the International Society of Sports Nutrition (2017) · Systematic review
Increases strength by 5-15%
Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults <50 Years of Age: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis · n=20
In comparison with a placebo, creatine supplementation combined with resistance training significantly increased upper-body (WMD = 4.43 kg, p < 0.001) and lower-body strength (WMD = 11.35 kg, p < 0.001).
Based on meta-analyses showing 5-15% strength increases. Upper-body improvements 4.43kg, lower-body 11.35kg. Effects plateau at therapeutic doses.
AI-estimated from published studies. Interpret as directional guidance.
Creatine has a higher evidence score (9.5/10 vs 5/10) and wins in 3 of 3 categories.
No known interactions between Armodafinil (Nuvigil) and Creatine have been documented in our database. However, always consult a healthcare provider before combining supplements.